FDA Determines Regulatory Review Period for BRYAN Cervical Disc System Patent Extension Application

Summary

The Food and Drug Administration (FDA) has determined the regulatory review period for BRYAN Cervical Disc System, a medical device, and is publishing this notice as required by law. The FDA made this determination due to a patent extension application submitted to the Director of Patents and Trademarks, Department of Commerce.